Startup Funding News
Explore funding rounds, the companies behind them and the investors taking part.
- Rounds
- 473 All time
- Disclosed funding
- $19.6B 400 disclosed amounts
- Median round
- $20M Of disclosed amounts
| Company | Amount | Round | Sector | Country | Investors | Announced |
|---|---|---|---|---|---|---|
| SP Develops next-generation peptide radioligand therapies for cancer | $18M | Series A | Biotech | United States | Investors | |
| P Pharmacelera uses quantum-mechanics methods and AI in drug discovery. | €6M | Growth | Biotech | Spain | Investors | |
| SB Sift BiosciencesCompany profile Develops next-generation peptide immunotherapy platform using AI metagenomics and high-throughput profiling to engage memory T cells for cancer and autoimmune diseases Develops next-generation peptide immunotherapy platform using AI metagenomics and high-throughput profiling to engage memory T cells for cancer and autoimmune diseases | $3.7M | Pre-SeedPre-seed | Biotech | United States | Investors | |
| BT Develops precision immune therapies for glioblastoma | €2.5M | StrategicUndisclosed | Biotech | Sweden | Investors | |
| SL Seek LabsCompany profile Develops a programmable disease response platform to detect protect and counter disease threats Develops a programmable disease response platform to detect protect and counter disease threats | $2M | GrantUndisclosed | Biotech | United States | Investors | |
| G GelMEDIXCompany profile Develops regenerative therapies to restore vision by regenerating damaged retinal cells Develops regenerative therapies to restore vision by regenerating damaged retinal cells | $13M | Seed | Biotech | United States | Investors | |
| B Provides AI-powered platform for bioprocess development and optimization | Undisclosed | StrategicUndisclosed | Biotech | United States | Investors | |
| OM OncoRes MedicalCompany profile Develops a hand-held real-time intraoperative imaging device to improve the detection of residual cancer during surgery Develops a hand-held real-time intraoperative imaging device to improve the detection of residual cancer during surgery | $27M | Growth | Biotech, Healthtech | Australia | Investors | |
| TB The Biological ComputingCompany profile Integrates living neurons with AI for more efficient computing Integrates living neurons with AI for more efficient computing | $25M | Seed | Biotech, Healthtech | United States | Investors | |
| L Loyal develops medicines intended to extend dogs’ lifespans. | $100M | Series CSeries C+ | Biotech | United States | Investors |
Active investors in this selection
All investors →Ranked by rounds participated in · All time
- 1RA Capital Management
Estuary Biotherapeutics, Circle Pharma, Inc., Solstice Oncology
22rounds3led - 2Janus Henderson Investors
Star Therapeutics, OMass Therapeutics, Soufflé Therapeutics
15rounds1led - 3Eli Lilly and Company
BigHat Biosciences, Circle Pharma, Inc., Moonwalk Biosciences
15rounds0led - 4ARCH Venture Partners
Soufflé Therapeutics, Encoded Therapeutics Inc., Moonwalk Biosciences
14rounds0led - 5OrbiMed
Star Therapeutics, Leal Therapeutics, Accro Bioscience
11rounds1led
Latest digests
Archive →Explore published rounds while the next edition is being prepared.
Browse rounds by topic
Geography
Featured selections
Nordic Foodtech Fund II pairs early capital with scientific expertise
An EIF pledge of up to €30m supports a fund targeting €80m for science-led agrifood companies.
Read the research →